88 FR 242 pgs. 87787-87788 - Apothecon, et al.; Withdrawal of Approval of 103 New Drug Applications and 35 Abbreviated New Drug Applications; Correction
Type: NOTICEVolume: 88Number: 242Pages: 87787 - 87788
Pages: 87787, 87788Docket number: [Docket No. FDA-2009-N-0026]
FR document: [FR Doc. 2023-27859 Filed 12-18-23; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0026]
Apothecon, et al.; Withdrawal of Approval of 103 New Drug Applications and 35 Abbreviated New Drug Applications; Correction
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice; correction.
SUMMARY:
[top] The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on February 11, 2009. The
FOR FURTHER INFORMATION CONTACT:
Kimberly Lehrfeld, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 6226, Silver Spring, MD 20993-0002, 301-796-3137, Kimberly.Lehrfeld@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
In the Federal Register of February 11, 2009 (74 FR 6896), appearing on page 6900 in FR Doc. E9-2901, the following correction is made:
On page 6900, in the table, in the first column, the Application No. for the entry for Amiodarone HCL Injection, 50 mg/mL held by Hospira Inc., 275 North Field Dr., Lake Forest, IL 60045-5046 is corrected to ANDA 76-108.
Dated: December 14, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-27859 Filed 12-18-23; 8:45 am]
BILLING CODE 4164-01-P